Article List
- Chemtrix MR555 microchannel reaction imported equipment is assembledChemtrix MR555 microchannel reaction imported equipment is assembled Date: 16-11-2020After three years of preparatio
- 2020 flow chemistry technology seminar held in ShenzhenI am honored to be invited to participate as CEO of Zhejiang Multinpharam Co.,Ltd in the 2020 flow chemistry technology seminar held in Shenzhen, I am also honored to communicate with 8 academicians attended, and 14 experts jointly proposed "Accelerating Basic Research on Flow
- Vitamins & Supplements TIANEPTINETianeptineOverview InformationTianeptine is a prescription drug for depression in some European, Asian, and Latin American countries. Tianeptine is not approved as a prescription drug or dietary supplement in the U.S.Tianeptine is most commonly used for depression. It is also used for pain, asthma,
- Pharmaceutical Process Development: Opportunities and Challenges in PatheonOn March 13, at Patheon's Linz Plant (formerly DSM) in Austria, Cheng Dang, a researcher from Fudan University, gave a "Pharmaceutical Process Development: Opportunities and Challenges" report to Patheon's R & D technical team, which was highly praised by Patheon's R & D technical team , Causing a l
- Pharmaceutical Process Development: Opportunities and Challenges in PatheonOn March 13, at Patheon's Linz Plant (formerly DSM) in Austria, Cheng Dang, a researcher from Fudan University, gave a "Pharmaceutical Process Development: Opportunities and Challenges" report to Patheon's R & D technical team, which was highly praised by Patheon's R & D technical team , Causing a l
- New Lab & Office-2022New Lab and Office for Promising future on chemical reaserch achievements and business ! Welcome to visit us ! office Video : https://video-c.ldycdn.com/mjBjnKirqo-qoilKBrnmiSRoirnnmljmiqmqr-8a9ac2042711404da3f85a54e7fc21d4.mp4
- Zhejiang Multinpharma Co.,LTD was invited to study in EuropeChemtrix microchannel reactor and industrial applicationFrom March 12 to March 14, 2018, at the invitation of Dr. Charlotte Wiles, CEO of Chemtrix BV of the Netherlands, Zhejiang Multinpharma Co., Ltd., Zhejiang Juxian Pharmaceutical Technology Co., Ltd., Shenzhen Yizheng Technology Co., Ltd. and it
- Zhejiang Multinpharma Co.,LTD was invited to study in EuropeChemtrix microchannel reactor and industrial applicationFrom March 12 to March 14, 2018, at the invitation of Dr. Charlotte Wiles, CEO of Chemtrix BV of the Netherlands, Zhejiang Multinpharma Co., Ltd., Zhejiang Juxian Pharmaceutical Technology Co., Ltd., Shenzhen Yizheng Technology Co., Ltd. and it